Chemoinformaics analysis of (+/-)-6-acetonyldihydrosanguinarine
Molecular Weight | 389.407 | nRot | 2 |
Heavy Atom Molecular Weight | 370.255 | nRig | 30 |
Exact Molecular Weight | 389.126 | nRing | 6 |
Solubility: LogS | -7.233 | nHRing | 3 |
Solubility: LogP | 4.684 | No. of Aliphatic Rings | 3 |
Acid Count | 0 | No. of Aromatic Rings | 3 |
Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
Atoms Count | 48 | No. of Aliphatic Hetero Cycles | 3 |
No. of Heavy Atom | 29 | No. of Aromatic Carbocycles | 3 |
nHetero | 6 | No. of Aromatic Hetero Cycles | 0 |
nBridge Head | 0 | No. Saturated Carbocycles | 0 |
No. of Hydrogen atom | 19 | No. of Saturated Hetero Cycles | 0 |
No. of Carbon atom | 23 | No. of Saturated Rings | 0 |
No. of Nitrogen atom | 1 | No. of Arom Atom | 16 |
No. of Oxygen atom | 5 | No. of Arom Bond | 17 |
nHA | 6 | APOL | 56.1891 |
nHD | 0 | BPOL | 28.5829 |
QED | 0.646 |
Synth | 3.424 |
Natural Product Likeliness | 1.197 |
NR-PPAR-gamma | 0.025 |
Lipinski | Accepted |
Pfizer | Rejected |
GSK | Rejected |
Golden Triangle | Accepted |
Pgp-inh | 0.011 |
Pgp-sub | 0.38 |
HIA | 0.002 |
CACO-2 | -4.815 |
MDCK | 0.000043 |
BBB | 0.089 |
PPB | 0.979403 |
VDSS | 0.482 |
FU | 0.0119388 |
CYP1A2-inh | 0.979 |
CYP1A2-sub | 0.198 |
CYP2c19-inh | 0.983 |
CYP2c19-sub | 0.273 |
CYP2c9-inh | 0.861 |
CYP2c9-sub | 0.935 |
CYP2d6-inh | 0.981 |
CYP2d6-sub | 0.93 |
CYP3a4-inh | 0.941 |
CYP3a4-sub | 0.366 |
CL | 15.75 |
T12 | 0.116 |
hERG | 0.044 |
Ames | 0.843 |
ROA | 0.162 |
SkinSen | 0.391 |
Carcinogencity | 0.962 |
EI | 0.036 |
Respiratory | 0.907 |
NR-Aromatase | 0.457 |
Antiviral | Yes |
Prediction | 0.701644 |